The Function of Small RNA-Based viral Defense System in E. coli
大肠杆菌中基于小RNA的病毒防御系统的功能
基本信息
- 批准号:10388674
- 负责人:
- 金额:$ 7.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR-associated genes)
loci are present in almost all archaea and half of eubacteria. They protect prokaryotes from foreign
genetic elements. While highly diverse, all CRISPR-Cas systems function through three common steps:
1) adaptation, i.e., acquisition of short foreign DNA sequences (spacers) into CRISPR arrays; 2)
production of mature protective CRISPR RNAs (crRNAs), and 3) interference, when Cas nucleases
guided by crRNAs destroy nucleic acids containing complementary targets. Studies of the interference
part of CRISPR response have revolutionized the field of genomic editing. The less-studied adaptation
part limits global horizontal gene transfer and can be harnessed for creation of DNA-based recording
devices and control of the spread of antibiotic resistance genes. Initial CRISPR immunity is built in the
course of “naïve”, non-discriminate acquisition of short intracellular DNA molecules – prespacers - as
spacers into CRISPR arrays. It occurs very infrequently and can lead to suicidal self-interference. A
remarkable mechanism called “priming” operates in type I CRISPR-Cas systems: acquisition of spacers
from DNA with sequences matching pre-existing spacers is dramatically stimulated compared to naïve
acquisition from DNA devoid of such sequences. Primed adaptation is highly beneficial to the host: it
rapidly leads to specific acquisition of additional interference-proficient spacers from genetic parasites
and ensures that no self-targeting spacers are selected. The mechanistic relationship between
interference and adaptation during priming is not fully clear. The goal of this proposal is to dissect
interrelationships between interference and adaptation during priming and to identify cellular processes
that feed the adaptation machinery during naïve and primed adaptation. We will use FragSeq - an
innovative high-throughput approach that identifies short intracellular DNA fragments and that was
developed during the previous funding period - to determine the structure of prespacers and of other in
vivo adaptation intermediates generated during naïve and primed adaptation in diverse CRISPR-Cas
systems classes and types, and identify non-Cas cellular proteins essential for prespacer generation and
spacer acquisition. The understanding of CRISPR adaptation that will result from our work will allow us
and others to optimize the efficiency of the adaptation process, facilitating construction of strains with
desired spacer content/immunity profiles and, by revealing processes that limit adaptation, may help
control viability of bacterial populations by inducing adaptation from cell’s own DNA and self-interference.
CRISPR-CAS(群集定期间隔间隔短的alindromic重复与危机相关基因)
他们保护原核生物免受外国的侵害
遗传因素。尽管高度多样化,但所有CRISPR-CAS系统通过三个共同的步骤运行:
1)适应,即,将简短的外源DNA序列(间隔者)获取为CRISPR阵列; 2)
生产成熟的受保护的CRISPR RNA(CRRNA),3)干扰,当CAS核病
在CRRNA的指导下破坏了包含完整靶标的核酸。干扰研究
CRISPR反应的一部分彻底改变了基因组编辑领域。研究较少的改编
零件限制全球水平基因转移,可以利用以创建基于DNA的记录
装置和抗生素耐药基因扩散的控制。最初的CRISPR免疫是内置的
“幼稚”的,无歧视的较短细胞内DNA分子的习得 - 预科剂 -
垫片进入CRISPR阵列。它很少发生,可能导致自杀的自我干扰。一个
称为“启动”的杰出机制在I型CRISPR-CAS系统中运行:获取垫片
与幼稚的
从没有此类序列的DNA获取。启动适应对宿主非常有益:它
迅速导致从遗传寄生虫中特异性获取其他干扰的垫片
并确保不选择自动靶向垫片。机械关系
启动过程中的干扰和适应尚不完全清楚。该提议的目的是剖析
启动过程中的干扰和适应性之间的相互关系并识别蜂窝过程
在幼稚和底漆适应过程中,可以供应适应机制。我们将使用fragseq-
创新的高通量方法可以识别出短的细胞内DNA片段,那就是
在上一个资金期间开发 - 确定预设的结构和其他
在潜水员CRISPR-CAS中生成的体内适应性中间体
系统类别和类型,并识别针对预知前生必不可少的非CAS细胞蛋白
辅助收购。对我们工作将导致的CRISPR改编的理解将使我们
以及其他以优化适应过程的效率的
所需的间隔含量/免疫概况,并通过揭示限制适应的过程,可能会有所帮助
通过诱导细胞自身的DNA和自身释放的适应性来控制细菌群体的生存能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
KONSTANTIN V SEVER...的其他基金
The function of small RNA-based viral defense system in E. coli
大肠杆菌中基于小RNA的病毒防御系统的功能
- 批准号:86064738606473
- 财政年份:2013
- 资助金额:$ 7.1万$ 7.1万
- 项目类别:
The function of small RNA-based viral defense system in E. coli
大肠杆菌中基于小RNA的病毒防御系统的功能
- 批准号:84207968420796
- 财政年份:2013
- 资助金额:$ 7.1万$ 7.1万
- 项目类别:
The Function of Small RNA-Based viral Defense System in E. coli - Renewal 1
大肠杆菌中基于小 RNA 的病毒防御系统的功能 - 更新 1
- 批准号:1033815410338154
- 财政年份:2013
- 资助金额:$ 7.1万$ 7.1万
- 项目类别:
The function of small RNA-based viral defense system in E. coli
大肠杆菌中基于小RNA的病毒防御系统的功能
- 批准号:87973338797333
- 财政年份:2013
- 资助金额:$ 7.1万$ 7.1万
- 项目类别:
The function of small RNA-based viral defense system in E. coli
大肠杆菌中基于小RNA的病毒防御系统的功能
- 批准号:89952118995211
- 财政年份:2013
- 资助金额:$ 7.1万$ 7.1万
- 项目类别:
GENOMIC AND PROTEOMIC ANALYSIS OF PHI32, A NOVEL ESCHERICHIA COLI PHAGE
新型大肠杆菌噬菌体 PHI32 的基因组和蛋白质组分析
- 批准号:81691508169150
- 财政年份:2010
- 资助金额:$ 7.1万$ 7.1万
- 项目类别:
GENOMIC AND PROTEOMIC ANALYSIS OF PHI32, A NOVEL ESCHERICHIA COLI PHAGE
新型大肠杆菌噬菌体 PHI32 的基因组和蛋白质组分析
- 批准号:79541187954118
- 财政年份:2009
- 资助金额:$ 7.1万$ 7.1万
- 项目类别:
Phage-induced modifications of RNA polymerase
噬菌体诱导的 RNA 聚合酶修饰
- 批准号:79334437933443
- 财政年份:2009
- 资助金额:$ 7.1万$ 7.1万
- 项目类别:
GENOMIC AND PROTEOMIC ANALYSIS OF PHI32, A NOVEL ESCHERICHIA COLI PHAGE
新型大肠杆菌噬菌体 PHI32 的基因组和蛋白质组分析
- 批准号:77222687722268
- 财政年份:2008
- 资助金额:$ 7.1万$ 7.1万
- 项目类别:
Novel Microcin C-based Inhibitors of Pathogenic Bacteria
基于 Microcin C 的新型病原菌抑制剂
- 批准号:77063157706315
- 财政年份:2008
- 资助金额:$ 7.1万$ 7.1万
- 项目类别:
相似国自然基金
嗜热古细菌淀粉普鲁兰酶双功能催化机制的解析与水解活性的定向进化
- 批准号:31671801
- 批准年份:2016
- 资助金额:63.0 万元
- 项目类别:面上项目
古细菌CCC1家族铁/锰离子跨膜转运蛋白的结构生物学研究
- 批准号:31200550
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
古细菌aDim2p、a/eIF2和核糖体30S亚基之间相互作用分子机制的初步研究
- 批准号:31070659
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
嗜热古细菌麦芽糖基淀粉酶催化异黄酮转糖基化反应机理的研究
- 批准号:31000760
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
古菌Sulfolobus tokodaii甘油醛脱氢酶及其对非磷酸化Entner-Doudoroff糖酵解代谢的调控机制
- 批准号:30900039
- 批准年份:2009
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Mechanism of Translation Initiation on Leaderless mRNAs
无领导者 mRNA 的翻译起始机制
- 批准号:1059380710593807
- 财政年份:2022
- 资助金额:$ 7.1万$ 7.1万
- 项目类别:
2022 Microbial Stress Response GRC/GRS
2022 微生物应激反应 GRC/GRS
- 批准号:1053700110537001
- 财政年份:2022
- 资助金额:$ 7.1万$ 7.1万
- 项目类别:
The mycobiota, bone marrow transplantation, and clinical outcomes
真菌群、骨髓移植和临床结果
- 批准号:1041520010415200
- 财政年份:2021
- 资助金额:$ 7.1万$ 7.1万
- 项目类别:
The mycobiota, bone marrow transplantation, and clinical outcomes
真菌群、骨髓移植和临床结果
- 批准号:1030367810303678
- 财政年份:2021
- 资助金额:$ 7.1万$ 7.1万
- 项目类别:
Defining CRISPR adaptation and interference mechanisms in E. coli
定义大肠杆菌中的 CRISPR 适应和干扰机制
- 批准号:1038760810387608
- 财政年份:2021
- 资助金额:$ 7.1万$ 7.1万
- 项目类别: